Potassium Chloride Tablet, Extended Release
Product Images NDC 72888-099

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Potassium Chloride (NDC 72888-099). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advagen Pharma Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Potassium Chloride Extended-release Tablets Usp, 10meq (NDC 72888-097-00)

Label for Potassium Chloride Extended-Release Tablets USP, 10 mEq strength, in a package containing 1000 tablets. Distributed by Advagen Pharma Limited, manufactured by Rubicon Research Private Limited in India. The label includes storage instructions, dosage guidance reference, and safety warnings along with barcodes and revision information.*

FDA Label Image

Potassium Chloride Extended-release Tablets Usp, 10meq (NDC 72888-097-01)

Label for Potassium Chloride Extended-Release Tablets, USP, 10 mEq strength, in a package of 100 tablets. The label includes distribution by Advagen Pharma Limited, manufacturing by Rubicon Research Private Limited in India, storage instructions, dosage warnings, and a barcode. The label also features the Advagen logo and indicates the product is prescription only.*

FDA Label Image

Potassium Chloride Extended-release Tablets Usp, 15meq (NDC 72888-098-00)

Label for Potassium Chloride Extended-Release Tablets, USP containing 15 mEq potassium per tablet. The label states a package size of 1000 tablets, marked Rx Only. Distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited. Includes storage instructions and safety warnings, with barcodes and revision information.*

FDA Label Image

Potassium Chloride Extended-release Tablets Usp, 15meq (NDC 72888-098-01)

Label for Potassium Chloride Extended-Release Tablets, USP 15 mEq by Advagen Pharma Ltd. The label specifies 100 tablets per container, extended-release oral dosage form, with storage and safety instructions. Manufactured by Rubicon Research Private Limited, India, with a lot number and revision date indicated. Contains standard barcodes and an overprinting area for additional labeling.*

FDA Label Image

Potassium Chloride Extended-release Tablets Usp, 20meq (NDC 72888-099-00)

Label for Potassium Chloride Extended-Release Tablets, USP 20 mEq strength, oral dosage form. The label indicates a package containing 1000 tablets. It shows NDC 72888-099-00, distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited. Storage and handling instructions are included, as well as warnings to keep out of reach of children.*

FDA Label Image

Potassium Chloride Extended-release Tablets Usp, 20meq (NDC 72888-099-01)

Label for Potassium Chloride Extended-Release Tablets, USP 20 mEq, oral tablets distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited. The blister or bottle label indicates a package size of 100 tablets, with storage and safety instructions including protection from light and moisture, and a child-resistant closure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.